Centralizing cancer care has been a hot topic for quite some time. Many argue that hospitals are often too small and treat too few patients. Only by pooling resources and specialists in comprehensive cancer centers could high-quality care and equal access to innovative therapies be guaranteed.
Yet, the Covid pandemic has shown that reducing the number of hospital beds may also be problematic for the quality of care. Broad availability of hospitals can help intercept epidemic outbreaks and maintain medical expertise – also in oncology.
How should the future of inpatient cancer care look like in Europe? Is centralization still the way forward, or do we need to maintain broad operational readiness and expertise?